Spruce Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
8.29
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
2
|
|
# Buys
|
4
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.53
|
-0.48
|
0.05
|
9.43%
|
|
2022-06-30
|
-0.52
|
-0.51
|
0.01
|
1.92%
|
|
2022-03-31
|
-0.46
|
-0.50
|
-0.04
|
-8.70%
|
|
2021-12-31
|
-0.54
|
-0.39
|
0.15
|
27.78%
|
|
2021-09-30
|
-0.57
|
-0.49
|
0.08
|
14.04%
|
|
2021-06-30
|
-0.45
|
-0.50
|
-0.05
|
-11.11%
|
|
2021-03-31
|
-0.42
|
-0.42
|
0.00
|
0.00%
|
|
2020-12-31
|
-0.59
|
-0.39
|
0.20
|
33.90%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.49
|
|
2021-12-31
|
-1.80
|
|
2020-12-31
|
-14.01
|